小动物体内成像市场规模、份额、成长分析、按模式、按试剂、按应用、按最终用户、按地区 - 产业预测，2025-2032 年

2023年，全球小动物体内影像市场规模为10.7亿美元，从2024年的11.5亿美元成长到2032年的21亿美元，在预测期间（2025-2032年）预计将以年复合成长率为7.8 %。

随着微型 MRI、微型 CT、微型 PET、多模态成像等微型仪器以及微型超音波和光学成像等新兴技术的进步，核医学成像技术市场正在不断发展。市场成长的主要驱动力包括不断增加的药品投资和临床前研究需求。然而，它们面临严格监管和报销不足的挑战，特别是在基础设施和熟练人力资源不足的新兴经济体。由于有利的报销政策和对先进成像系统的大量投资，北美占据全球市场 35% 的份额。另一方面，亚太地区预计将以11.5%的复合年增长率稳定成长。 COVID-19 大流行暂时扰乱了供应链和需求，影响了市场动态。总体而言，负担得起的技术商业化对于产业扩张仍然至关重要。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析
• 案例研究
• 技术进步
• 监管环境

小动物体内影像市场规模：依方式分类

• 市场概况
• 光学成像系统
  • 生物发光成像
  • 萤光影像
• 核子造影系统
  • 正子断层扫描 (PET)
  • 单光子发射电脑断层扫描 (SPECT)
• 磁振造影（MRI）系统
• 电脑断层扫描 (CT) 系统
• 超音波影像成像系统
• 光声成像系统

小动物体内成像市场规模：依试剂划分

• 市场概况
• 光学成像试剂
• 核子造影试剂
• MRI显影剂
• 超音波显影剂
• CT显影剂

小动物体内影像市场规模：依应用分类

• 市场概况
• 生物分布研究
• 癌细胞检测
• 生物标誌物
• 纵贯研究
• 医药开发
• 功能和解剖图像

小动物体内影像市场规模：依最终用户划分

• 市场概况
• 製药和生物技术公司
• 学术研究所
• 合约研究组织（CRO）
• 医院和诊所

小动物体内成像市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Bruker Corporation（US）
• PerkinElmer, Inc.（US）
• FUJIFILM Holdings Corporation（Japan）
• Siemens Healthineers AG（Germany）
• Miltenyi Biotec（Germany）
• Aspect Imaging（Israel）
• Thermo Fisher Scientific Inc.（US）
• GE Healthcare（US）
• Mediso Ltd.（Hungary）
• MR Solutions Ltd.（UK）
• TriFoil Imaging（US）
• Key Developments
• Agilent Technologies, Inc.（US）
• Hitachi Ltd.（Japan）
• Canon Medical Systems Corporation（Japan）

结论和建议

Global Small Animal Imaging In Vivo Market size was valued at USD 1.07 billion in 2023 and is poised to grow from USD 1.15 billion in 2024 to USD 2.1 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The nuclear imaging technology market is evolving with advancements in micro-level equipment, including micro MRI, micro CT, and micro PET, as well as multimodal imaging and emerging techniques like micro-ultrasound and optical imaging. Key drivers of market growth include increasing pharmaceutical investments and pre-clinical research needs. However, stringent regulations and inadequate reimbursement pose challenges, particularly in developing economies with insufficient infrastructure and skilled personnel. North America leads, dominating the global market with a 35% share due to favorable reimbursement policies and significant investments in advanced imaging systems. Meanwhile, the Asia-Pacific region is anticipated to experience robust growth at a CAGR of 11.5%. The COVID-19 pandemic has temporarily disrupted supply chains and demand, impacting market dynamics. Overall, affordable technology commercialization remains crucial for industry expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Small Animal Imaging In Vivo market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Small Animal Imaging In Vivo Market Segmental Analysis

Global Small Animal Imaging In Vivo Market is segmented by Modality, Reagents, Application, End-User and region. Based on Modality, the market is segmented into Optical Imaging Systems, Nuclear Imaging Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Systems, Ultrasound Imaging Systems and Photoacoustic Imaging Systems. Based on Reagents, the market is segmented into Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents and CT Contrast Agents. Based on Application, the market is segmented into Biodistribution Studies, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Drug Development and Functional and Anatomical Imaging. Based on End-User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs) and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Small Animal Imaging In Vivo Market

The global Small Animal Imaging In Vivo market is poised for growth driven by several key factors. The increasing adoption of multimodal imaging technologies is anticipated to significantly enhance market expansion throughout the forecast period. Additionally, rising healthcare expenditures are expected to bolster the small animal imaging sector. The preference for non-invasive imaging solutions is also gaining traction, further propelling market growth. Contributing factors include higher disposable incomes and urbanization trends, which create a more conducive environment for technological advancements. Furthermore, the growing investment in healthcare infrastructure is a significant driving force, particularly in oncology applications, as cancer rates rise worldwide.

Restraints in the Global Small Animal Imaging In Vivo Market

The growth of the small animal in vivo imaging market is anticipated to be hampered by several factors during the projected period. Key restraints include the high costs associated with imaging equipment and existing technological limitations. Additionally, there is a significant shortage of skilled professionals in emerging markets, compounded by insufficient research facilities and infrastructure. The market will also encounter challenges due to low healthcare expenditure in developing countries and the absence of standardized practices. Furthermore, limited awareness and a scarcity of qualified experts will constrain the overall growth rate of the small animal imaging sector from 2022 to 2028.

Market Trends of the Global Small Animal Imaging In Vivo Market

The Global Small Animal Imaging In Vivo market is experiencing significant growth driven by the surging demand for non-invasive imaging techniques. This trend is propelled by the expansion of pharmaceutical companies and research institutions, bolstered by funding from public and private sectors for innovative developments. Moreover, advancements across multiple disciplines such as chemistry, computer science, engineering, medicine, and molecular biology are enhancing imaging capabilities. The period from 2021 to 2028 is expected to witness further opportunities, particularly due to rising demand in emerging economies and intensified R&D initiatives, positioning the market for sustained expansion and innovation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape

Global Small Animal Imaging In Vivo Market Size by Modality & CAGR (2025-2032)

• Market Overview
• Optical Imaging Systems
  • Bioluminescence Imaging
  • Fluorescence Imaging
• Nuclear Imaging Systems
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
• Magnetic Resonance Imaging (MRI) Systems
• Computed Tomography (CT) Systems
• Ultrasound Imaging Systems
• Photoacoustic Imaging Systems

Global Small Animal Imaging In Vivo Market Size by Reagents & CAGR (2025-2032)

• Market Overview
• Optical Imaging Reagents
• Nuclear Imaging Reagents
• MRI Contrast Agents
• Ultrasound Contrast Agents
• CT Contrast Agents

Global Small Animal Imaging In Vivo Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biodistribution Studies
• Cancer Cell Detection
• Biomarkers
• Longitudinal Studies
• Drug Development
• Functional and Anatomical Imaging

Global Small Animal Imaging In Vivo Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions
• Contract Research Organizations (CROs)
• Hospitals and Clinics

Global Small Animal Imaging In Vivo Market Size & CAGR (2025-2032)

• North America (Modality, Reagents, Application, End-User)
  • US
  • Canada
• Europe (Modality, Reagents, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Modality, Reagents, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Modality, Reagents, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Modality, Reagents, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspect Imaging (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriFoil Imaging (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations